HDL-P Test

The big picture: HDL-P refers to the number of high-density lipoprotein (HDL) particles in the bloodstream. Unlike HDL-C, which measures the amount of cholesterol within HDL particles, HDL-P provides a more accurate measure of the actual particle count, offering insights into cardiovascular health. Higher HDL-P levels are associated with better protection against atherosclerosis and cardiovascular disease (CVD), as HDL particles play a crucial role in reverse cholesterol transport, moving cholesterol from the arteries to the liver for excretion.

Role in cardiovascular health: HDL particles are responsible for removing excess cholesterol from the bloodstream and arterial walls through a process known as reverse cholesterol transport. This process helps reduce plaque formation and atherosclerosis, lowering the risk of heart attacks and strokes. The more HDL particles present in the blood, the more efficient this cholesterol removal process becomes. Therefore, a higher HDL-P count is considered protective against cardiovascular disease, while lower HDL-P levels may indicate an increased risk, even in individuals with normal or high HDL cholesterol levels.

HDL-P vs. HDL-C: While HDL-C measures the amount of cholesterol contained within HDL particles, it doesn’t necessarily reflect the functionality or number of HDL particles. Two individuals can have the same HDL-C level but very different HDL-P counts, leading to differing cardiovascular risks. Research has shown that HDL-P is a stronger predictor of heart disease risk than HDL-C, as it directly measures the number of particles capable of removing cholesterol. In cases of discordance between HDL-C and HDL-P, HDL-P often provides more accurate risk assessment.

Clinical significance: Higher HDL-P levels are strongly correlated with a lower risk of cardiovascular events, including heart attacks and strokes. Conversely, low HDL-P levels, even when HDL-C is normal, may indicate a higher risk of cardiovascular disease. HDL-P is particularly useful for assessing risk in individuals with metabolic syndrome, diabetes, or other conditions that affect lipid metabolism, as these individuals often have fewer but cholesterol-rich HDL particles, reducing the efficiency of reverse cholesterol transport.